Novo Holdings has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $1.23 Billion distributed in 34 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Vanguard Total Stock Market Et with a value of $301M, Edgewise Therapeutics, Inc. with a value of $134M, Asml Holding Nv with a value of $115M, Salesforce, Inc. with a value of $98.3M, and Recursion Pharmaceuticals, Inc. with a value of $68.4M.

Examining the 13F form we can see an decrease of $199M in the current position value, from $1.43B to 1.23B.

Novo Holdings is based out at Hellerup, G7

Below you can find more details about Novo Holdings portfolio as well as his latest detailed transactions.

Portfolio value $1.23 Billion
Healthcare: $677 Million
ETFs: $301 Million
Technology: $215 Million
Consumer Cyclical: $38.4 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 34
  • Current Value $1.23 Billion
  • Prior Value $1.43 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 3 stocks
  • Additional Purchases 6 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Novo Holdings Portfolio

Follow Novo Holdings and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

News

Stay updated on Novo Holdings with notifications on news.